Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
A UC Davis Health study finds that the antiviral tecovirimat appears to be safe and effective for the treatment of monkeypox symptoms and skin lesions. The study is one of the earliest studies to assess and report the outcomes of treating patients with monkeypox with this antiviral.
https://health.ucdavis.edu/coronavirus/news/headlines/uc-davis-health-study-reports-on-the-safety-efficacy-of-tecovirimat-in-treating-monkeypox/2022/08
Brazil's health agency just approved the exemption to register to import Tpoxx.
https://www.plenglish.com/news/2022/08/26/anvisa-authorizes-use-of-vaccine-and-drug-against-monkeypox-in-brazil/
Monkeypox medicine tecovirimat will be available in New Zealand from late September.
https://www.1news.co.nz/2022/08/26/monkeypox-medicine-secured-by-govt-for-late-september/
That is a huge range today Day Range: low 17.78 - 21.16 high like a $3.5/share span...
It may track the Bio-tech/Drug firm and Nasdaq indexes in part... I the market wide drop and Bio-tech-drug stop drop was double hit, with over bought got us down this far. Short today and many be Friday may be good short term buys for 1-2 day bounce at a minimum...
Shorts will want cover on Wednesday next week, unless news presses them to cover.
https://www.jpost.com/health-and-wellness/coronavirus/article-715514
The Jerusalem Post | JPost.com
Man tests positive for COVID-19, monkeypox and HIV all at once
It is as of yet unclear if monkeypox, SARS-CoV-2 and HIV co-infection aggravate the patient's condition. They must be joking.
Harris Count jail inmate just tested positive for Monkey Pox. So, it is now an issue for jails, and Hospitals will be needing to watch for carriers...
3 Kids in Georgia also tested positive this week for Monkey Pox
10:1 PE is $9.00
20:1 PE is $18.00 historical
Earnings will see a huge jump on the financials
We could see the bottom today or friday, before a huge bounce. With out more news.
With News $36-$37 could be the next highs
Gonna Rip, but its gonna dip to about 10 before it does. Only because September is coming and its historically the worst month for the stock market.
No, not rebounding like it was
Me too. Second drop here was a not anticipated though.
https://www.barchart.com/stocks/quotes/SIGA/cheat-sheet
No idea...added more
How low will she go? Lol!
All the cards in this game haven’t been played yet!
Why do you say that ? Just because of the drop ?
The whole Biotech sector is down today, index funds IMO. In the news 3 kids in Georgia reported to have Monkeypox today.
I will adding the gifts on these dips.
That was the dip opp for today imo...GLTA
Awesome DD , please keep it coming. $SIGA could be the next Moderna $100 land share price monster...
They have started enrollment on a clinical trial of TPOXX in the UK. The name of the trial is PLATINUM.
https://platinumtrial.ox.ac.uk
$SIGA winner
VCU Medical Center lowers barriers to access monkeypox treatment Tpoxx
Removing obstacles facing our community
August 22, 2022
$SIGA
https://www.vcuhealth.org/news/vcu-medical-center-lowers-barriers-to-access-monkeypox-treatment
The PLATINUM trial, funded by a 3.7 million pound ($4.35 million) UK government grant, aims to recruit at least 500 participants. Participants will either be given a 14-day course of tecovirimat twice daily, or a placebo.
To assess the drug's effectiveness, the rate at which lesions heal, the time taken until patients test negative for the virus, and the proportion of patients who require hospitalisation due to complications will be tracked.
"I'm hoping that we can have a result before Christmas, but it depends on the rate of recruitment," said Sir Peter Horby, Professor of Emerging Infections and Global Health at the University of Oxford and the director of the new Pandemic Sciences Institute.
https://www.reuters.com/business/healthcare-pharmaceuticals/british-scientists-behind-key-covid-trial-launch-study-test-monkeypox-treatment-2022-08-23/?taid=6304afb3b596c2000132a321&utm_campaign=trueanthem&utm_medium=trueanthem&utm_source=twitter
August 22, 2022 huge$
Compassionate Use of Tecovirimat for the Treatment of Monkeypox Infection
https://jamanetwork.com/journals/jama/fullarticle/2795743?guestAccessKey=300cc546-00c4-47df-99d6-0a606da1e210&utm_source=silverchair&utm_medium=email&utm_campaign=article_alert-jama&utm_content=olf&utm_term=082222
$SIGA winner
MONKEYPOX NEWS. TOPXX
MONKEYPOX NEWS: In the coming weeks, #NIAID plans to initiate clinical trials evaluating the antiviral tecovirimat (TPOXX) for #monkeypox and a clinical trial evaluating dose-sparing regimens of JYNNEOS, a vaccine approved to prevent monkeypox. Read more https://t.co/jtHxVdcXSd pic.twitter.com/IQf5zBgHJN
— NIAID News (@NIAIDNews) August 22, 2022
On the ninth day of symptoms, he began treatment with oral tecovirimat, 600 mg twice daily. His pain improved within the following 36 hours, and no new skin lesions formed.He reported no adverse effects!
$SIGA winner
https://www.acpjournals.org/doi/10.7326/L22-0300#.YwJT1IpL37o.twitter
$20 move in 2 months
We are on track to that $75
Mark
GLTA
$SIGA
#ELGORDODAMUS
Yes, Sir............
Every $SIGA dip has been buy since May, a higher low, followed by higher highs..
Gotta love it...
While the market is in cash, jump out the top floor windows mode the last 2 days and even worse today, $SIGA is green today, must be the strong genes, swimming up steam like Salmon to spawn higher share prices.
I like it.....
TPOXX Is the Only Treatment Available for Monkeypox—Here's What To Know
https://www.health.com/news/tpoxx-monkeypox-treatment
this is normal, before launch!
Even though I’m drunk, I can surmise that they wouldn’t do that unless they were going to give an EUA at some point in the reasonably near future. Of course, I could easily be wrong in my condition. But hey … cheers !
The 50,000 placement of courses Monday will give rise to the final US approval of SIGA treatment
Why such volatility with this stock?
news: And officials outlined new efforts to make the treatment for monkeypox, Tpoxx, easier to access.
"Next week, HHS will be pre-positioning 50,000 courses of Tpoxx across the country. That's nearly five times as many treatment courses than confirmed cases in the US. These courses will be made available to jurisdictions where the outbreak is most severe so that individuals can get treatment more quickly from their healthcare providers," Fenton said.
The allocation will rely on a formula based 75% on the number of cases in a jurisdiction and 25% on the number of individuals at risk.
https://www.weny.com/story/47116994/first-on-cnn-biden-officials-accelerating-monkeypox-vaccine-effort-with-18-million-additional-doses-and-other-steps
I'm hoping for 10's so I can load up more.
Volume has been steadily decreasing for two weeks. I wouldn’t be surprised to see $20 or even $18.
Detroit Labor unions cancelling Labor Day marches because of high rates of Covid and Monkeypox !!!
Institutional Shares -29,101,384 39.85% new!
Clinical trials for Siga Technologies Inc.’s monkeypox treatment will start as early as next week in the UK as the outbreak continues to grow, the company’s chief scientific officer told Bloomberg Law.
The UK studies will mark the first of a dozen clinical trial sites to launch around the world under the latest outbreak, Dennis E. Hruby, Siga’s executive vice president and chief scientific officer, said in an interview Tuesday.
US studies run by the National Institutes of Health are set to follow mid-September, and Canada isn’t far behind, he added.
"At some point a large volumw but will take place"
"the Stock market is a place which transfers money FROM the Impatient TO the Patient" , So be patient.
$SIGA winner
https://news.bloomberglaw.com/pharma-and-life-sciences/uk-to-begin-sigas-monkeypox-drug-trials-as-soon-as-next-week
Smallpox vaccines may not protect against monkeypox for life:
https://amp.theguardian.com/world/2022/aug/15/smallpox-vaccines-protect-monkeypox-hiv-erode
Followers
|
49
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
1361
|
Created
|
09/25/06
|
Type
|
Free
|
Moderators |
SIGA Technologies, Inc. (Nasdaq: SIGA) is a commercial-stage pharmaceutical company focused on the health security market. Health security comprises countermeasures for biological, chemical, radiological and nuclear attacks (biodefense market), vaccines and therapies for emerging infectious diseases, and health preparedness. Our lead product is TPOXX®, also known as tecovirimat and ST-246®, an orally administered and IV formulation antiviral drug.
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |